Genetic analysis of SIRT1 gene promoter in sporadic Parkinson's disease

Biochemical and Biophysical Research Communications

Volumn 422, Issue 4, 2012, Pages 693-696

  Zhang, Aimei ^a   Wang, Hongen ^a   Qin, Xianyun ^a   Pang, Shuchao ^a   Yan, Bo ^a  

^a JINING MEDICAL UNIVERSITY   (China)

Author keywords

Parkinson's disease; Promoter; Sequence variant; SIRT1

Indexed keywords

SIRTUIN 1;

AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC CODE; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; HUMAN TISSUE; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; DNA MUTATIONAL ANALYSIS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; PARKINSON DISEASE; PROMOTER REGIONS, GENETIC; SIRTUIN 1;

ANIMALIA;

EID: 84862300236     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.05.059     Document Type: Article

References (47)

1. Devine M.J., Gwinn K., Singleton A., Hardy J. Parkinson's disease and α-synuclein expression. Mov. Disord. 2011, 26:2160-2168.
2. Corti S., Lesage A., Brice A. What genetics tells us about the causes and mechanisms of Parkinson's disease. Physiol. Rev. 2011, 91:1161-1218.
3. Martin V.L., Dawson T.M. Recent advances in the genetics of Parkinson's disease. Annu. Rev. Genomics Hum. Genet. 2011, 12:301-325.
4. Shulman J.M., De Jager P.L., Feany M.B. Parkinson's disease: genetics and pathogenesis. Annu. Rev. Pathol. 2011, 6:193-222.
5. Imai S., Armstrong C.M., Kaeberlein M., Guarente L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 2000, 403:795-800.
6. Finkel T., Deng C.X., Mostoslavsky R. Recent progress in the biology and physiology of sirtuins. Nature 2009, 460:587-591.
7. Houtkooper R.H., Pirinen E., Auwerx J. Sirtuins as regulators of metabolism and healthspan. Nat. Rev. Mol. Cell. Biol. 2012, 13:225-238.
8. Nakagawa T., Guarente L. Sirtuins at a glance. J. Cell. Sci. 2011, 124:833-838.
9. Araki T., Sasaki Y., Milbrandt J. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 2004, 305:1010-1013.
10. Donmez G., Wang D., Cohen D.E., Guarente L. SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10. Cell 2010, 142:320-332.
11. Kim D., Nguyen M.D., Dobbin M.M., et al. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J. 2007, 26:3169-3179.
12. Jeong H., Cohen D.E., Cui L., et al. Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway. Nat. Med. 2011, 18:159-165.
13. Jiang M., Wang J., Fu J., et al. Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets. Nat. Med. 2011, 18:153-158.
14. Albani D., Polito L., Batelli S., et al. The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by alpha-synuclein or amyloid-beta (1-42) peptide. J. Neurochem. 2009, 110:1445-1456.
15. Donmez G., Arun A., Chung C.Y., McLean P.J., Lindquist S., Guarente L. SIRT1 protects against α-synuclein aggregation by activating molecular chaperones. J. Neurosci. 2012, 32:124-132.
16. Cheng H.L., Mostoslavsky R., Saito S., et al. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc. Natl. Acad. Sci. USA 2003, 100:10794-10799.
17. McBurney M.W., Yang X., Jardine K., et al. The mammalian SIR2alpha protein has a role in embryogenesis and gametogenesis. Mol. Cell. Biol. 2003, 23:38-54.
18. Clark S.J., Falchi M., Olsson B., et al. Association of sirtuin 1 (SIRT1) gene SNPs and transcript expression levels with severe obesity. Obesity (Silver Spring) 2012, 20:178-185.
19. Dong Y., Guo T., Traurig M., et al. SIRT1 is associated with a decrease in acute insulin secretion and a sex specific increase in risk for type 2 diabetes in Pima Indians. Mol. Genet. Metab. 2011, 104:661-665.
20. Zillikens M.C., van Meurs J.B., Rivadeneira F., et al. SIRT1 genetic variation is related to BMI and risk of obesity. Diabetes 2009, 58:2828-2834.
21. Frye R.A. Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. Biochem. Biophys. Res. Commun. 1999, 260:273-279.
22. Bai P., Canto C., Brunyánszki A., et al. PARP-2 regulates SIRT1 expression and whole-body energy expenditure. Cell. Metab. 2011, 13:450-460.
23. Chen W.Y., Wang D.H., Yen R.C., Luo J., Gu W., Baylin S.B. Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses. Cell 2005, 123:437-448.
24. Han L., Zhou R., Niu J., McNutt M.A., Wang P., Tong T. SIRT1 is regulated by a PPAR{γ}-SIRT1 negative feedback loop associated with senescence. Nucleic Acids Res. 2010, 38:7458-7471.
25. Nemoto S., Fergusson M.M., Finkel T. Nutrient availability regulates SIRT1 through a forkhead-dependent pathway. Science 2004, 306:2105-2108.
26. Noriega L.G., Feige J.N., Canto C., et al. CREB and ChREBP oppositely regulate SIRT1 expression in response to energy availability. EMBO Rep. 2011, 12:1069-1076.
27. Pallàs M., Pizarro J.G., Gutierrez-Cuesta J., et al. Modulation of SIRT1 expression in different neurodegenerative models and human pathologies. Neuroscience 2008, 154:1388-1397.
28. Ciechanover A. Proteolysis: from the lysosome to ubiquitin and the proteasome. Nat. Rev. Mol. Cell. Biol. 2005, 6:79-87.
29. Ravikumar S., Sarkar J.E., Davies, et al. Regulation of mammalian autophagy in physiology and pathophysiology. Physiol. Rev. 2010, 90:1383-1435.
30. Levine B., Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008, 132:27-42.
31. Levine B., Mizushima N., Virgin H.W. Autophagy in immunity and inflammation. Nature 2011, 469:323-335.
32. Mizushima N., Komatsu M. Autophagy: renovation of cells and tissues. Cell 2011, 147:728-741.
33. Banerjee R., Beal M.F., Thomas B. Autophagy in neurodegenerative disorders: pathogenic roles and therapeutic implications. Trends Neurosci. 2010, 33:541-549.
34. Wong E., Cuervo A.M. Autophagy gone awry in neurodegenerative diseases. Nat. Neurosci. 2010, 13:805-811.
35. Lee I.H., Cao L., Mostoslavsky R., et al. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc. Natl. Acad. Sci. USA 2008, 105:3374-3379.
36. Morselli E., Maiuri M.C., Markaki M., et al. Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy. Cell. Death. Dis. 2010, 1:e10.
37. Wu Y., Li X., Zhu J.X., et al. Resveratrol-activated AMPK/SIRT1/autophagy in cellular models of Parkinson's disease. Neurosignals 2011, 19:163-174.
38. Haigis M.C., Sinclair D.A. Mammalian sirtuins: biological insights and disease relevance. Annu. Rev. Pathol. 2010, 5:253-295.
39. Livesey K.M., Kang R., Vernon P., et al. P53/HMGB1 complexes regulate autophagy and apoptosis. Cancer Res. 2012, 72:1996-2005.
40. Tasdemir E., Maiuri M.C., Galluzzi L., et al. Regulation of autophagy by cytoplasmic p53. Nat. Cell. Biol. 2008, 10:676-687.
41. Crighton D., Wilkinson S., O'Prey J., et al. DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 2006, 126:121-134.
42. Du Y., Yang D., Li L., et al. An insight into the mechanistic role of p53-mediated autophagy induction in response to proteasomal inhibition-induced neurotoxicity. Autophagy 2009, 5:663-675.
43. Barré B., Perkins N.D. The Skp2 promoter integrates signaling through the NF-kappaB, p53, and Akt/GSK3beta pathways to regulate autophagy and apoptosis. Mol. Cell 2010, 38:524-538.
44. Djavaheri-Mergny M., Amelotti M., Mathieu J., et al. NF-kappaB activation represses tumor necrosis factor-alpha-induced autophagy. J. Biol. Chem. 2006, 281:30373-30382.
45. Nivon M., Richet E., Codogno P., Arrigo A.P., Kretz-Remy C. Autophagy activation by NFkappaB is essential for cell survival after heat shock. Autophagy 2009, 5:766-783.
46. Mudò G., Mäkelä J., Di Liberto V., et al. Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson's disease. Cell. Mol. Life Sci. 2012, 69:1153-1165.
47. Lavu S., Boss O., Elliott P.J., Lambert P.D. Sirtuins-novel therapeutic targets to treat age-associated diseases. Nat. Rev. Drug Discov. 2008, 7:841-853.